NCT01364974View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Healthy SubjectsPharmacokinetics of ASP015KPharmacodynamics
Interventions
DRUG

ASP015K

oral

DRUG

Placebo

oral

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01364974 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K | Biotech Hunter | Biotech Hunter